| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.32B | -9.8% |
| Cost of Revenue | $988.8M | -10.1% |
| Gross Profit | $327.6M | -9.1% |
| R&D Expense | $67.5M | +3.5% |
| SG&A Expense | $310.0M | +8.7% |
| Operating Income | -$50.0M | -615.6% |
| Interest Expense | $13.2M | -24.2% |
| Pre-tax Income | -$61.7M | -1672.3% |
| Income Tax | $21.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $218.6M | -13.7% |
| Inventory | $260.0M | +8.2% |
| Current Assets | $623.4M | -12.4% |
| Total Assets | $1.24B | -9.0% |
| Current Liabilities | $396.3M | -5.3% |
| Long-term Debt | $173.5M | -12.4% |
| Total Liabilities | $616.4M | -7.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $35.9M | -59.8% |
| Capital Expenditures | $9.8M | -22.8% |
| Investing Cash Flow | -$52.7M | -95.3% |
| Financing Cash Flow | -$50.7M | -35.6% |
| Free Cash Flow | $26.0M | -65.9% |
| +990.1% |
| Net Income | -$85.2M | -3188.8% |
| EPS (Basic) | -$0.95 | -3266.7% |
| EPS (Diluted) | -$0.95 | -3266.7% |
| Stockholders' Equity |
| $604.3M |
| -9.5% |